Gilmore Neil O'Neill - 02 Jun 2022 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role: CEO, Director
Signature: /s/ Gilmore O'Neill
Issuer symbol: EDIT
Transactions as of: 02 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 06 Jun 2022, 16:44:26 UTC
Previous filing: 06 Jun 2022
Next filing: 27 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EDIT	Common Stock	Award	$0	+86,655		$0.000000	86,655	02 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EDIT	Stock Option (right to buy)	Award	$0	+950,209		$0.000000	950,209	02 Jun 2022	Common Stock	950,209	$11.54	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on June 2, 2023 continuing through June 2, 2026.
F2	This option was granted on June 2, 2022 and is scheduled to vest over four years, with 25% of the shares scheduled to vest on June 2, 2023 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through June 2, 2026.